Analyst / Investor Meet - Intimation
Analysts/Investors Meet-Reg.11-10-2017
Board Meeting Of The Company Will Be Held On 28Th October 2017 At 11.Am.
Board meeting of The Company will be held on 28th October 2017 at 11.am.09-10-2017
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for JM Financial Products Ltd05-10-2017
Outcome of AGM
Proceedings of Annual General Meeting of Nath Bio Genes India Limited held on 24.08.2017.24-08-2017
Standalone Financial Results, Limited Review Report for June 30, 2017
Nath Bio-Genes (India) Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20172. Standalone Limited Review for the period ended June 30, 201731-07-2017
Shareholding for the Period Ended June 30, 2017
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here21-07-2017
Statement Of Investor Complaints For Quarter Ending 30Th June 2017.
statement of Investor complaints for quarter ending 30th June 2017.15-07-2017
The Meeting Of Board Of Directors Will Be Held On 31.07.2017 For Approve The Unaudited Financial Results .
The meeting of Board of Directors will be held on 31.07.2017 for approve the unaudited financial results .14-07-2017